IIS are studies that are initiated and managed by a nonpharmaceutical company researcher, largely driven by questions that arise beyond the completion of Phase III studies that have not been studied during Phases I–III of drug development. Our knowledgeable and highly qualified clinical research, medical and scientific affairs team are ready to collaborate with you for any IIS related to our product or studies which can enlighten the scientific community of innovative solutions to tackle AMR or promote AMS.

Through our multidisciplinary approach, we provide highly efficient interactions with you and your teams.

We also provide support in designing the right protocol to address the right question based on a deep understanding of your needs, the regulatory requirements, and your specific scientific questions till closeout and generating a publication in a peer-reviewed journal.